We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Rubicon Research announced the acquisition of MeditabSpecialities’ oral liquid dosage and nasal product manufacturing facility located in Satara, Maharashtra. MeditabSpecialities is a wholly-owned subsidiary of Cipla.
Everstone’s Singapore fund had acquired a controlling stake in Rubicon and along with co-investor Mankekars, bought out Kotak Private Equity and other shareholders and also invested primary capital in the company